Aspirin for primary prevention of cardiovascular and all‐cause mortality events in diabetes: updated meta‐analysis of randomized controlled trials

Aims To evaluate the benefits and harms of aspirin for the primary prevention of cardiovascular disease and all‐cause mortality events in people with diabetes by conducting a systematic review and meta‐analysis. Methods Randomized controlled trials of aspirin compared with placebo (or no treatment) in people with diabetes with no history of cardiovascular disease were identified from MEDLINE , EMBASE , Web of Science, the Cochrane Library and a...